Investor profile
Exceptional Ventures has backed 17 European tech companies across 19 funding rounds between 2022 and 2026, joining rounds totalling €97M. Most active in Healthtech and AI. Data as of 6 Aug 2026.
Also recorded as: Exceptional Capital
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Evaro | UK | 2 | €22M |
| Gradient Labs | UK | 2 | €22M |
| SAVA | UK | 1 | €17M |
| Rest Less | UK | 1 | €6.9M |
| Jove | UK | 1 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Evaro | Series A | €21M | 2026-01 |
| SAVA | Series A | €17M | 2025-07 |
| Gradient Labs | Series A | €11M | 2026-06 |
| Gradient Labs |
| €4.3M |
| BonusX | Italy | 1 | €3.2M |
| Pacifico Biolabs | Germany | 1 | €3.1M |
| OpenHealth Technologies | Germany | 1 | €2.6M |
| Clerkenwell Health | UK | 1 | €2.4M |
| Punto Health | UK | 1 | €2.3M |
| Alba Health | Sweden | 1 | €2.2M |
| ReportAId | Italy | 1 | €2.2M |
| Juniper | UK | 1 | €1.8M |
| Gladys | UK | 1 | €1.7M |
| Amatera | France | 1 | €1.5M |
| Unfabled | UK | 1 | €1.4M |
| Preactiv | UK | 1 | €591k |
| €11M |
| 2025-07 |
| Rest Less | Other | €6.9M | 2022-12 |
| Jove | Seed | €4.3M | 2024-12 |
| BonusX | Seed | €3.2M | 2023-10 |
| Pacifico Biolabs | Pre-Seed | €3.1M | 2024-02 |
| OpenHealth Technologies | Seed | €2.6M | 2025-09 |
| Clerkenwell Health | Seed | €2.4M | 2022-10 |
